from basic cancer research to innovative therapiesyona keisari tel-aviv university mary-claire king...

Ittai Ben Porath Hebrew University of Jerusalem Yosef Buganim Hebrew University of Jerusalem Arkaitz Carracedo CIC bioGUNE Webster Cavenee Ludwig Institute for Cancer Research, UCSD Rony Dahan Weizmann Institute of Science John Dick UHN and University of Toronto Ayelet Erez Weizmann Institute of Science Neta Erez Tel-Aviv University Naama Geva-Zatorsky Technion Eyal Gottlieb Technion Yona Keisari Tel-Aviv University Mary-Claire King University of Washington Alan Korman Bristol-Meyers-Squibb Valery Krizhanovsky Weizmann Institute of Science Scott Lowe Memorial Sloan Kettering Cancer Center David Malkin Hospital for Sick Children & University of Toronto George Miller New York University Moshe Oren Weizmann Institute of Science Gideon Rechavi Sheba Medical Center Varda Rotter Weizmann Institute of Science Yardena Samuels Weizmann Institute of Science Avigdor Scherz Weizmann Institute of Science Ruth Scherz-Shouval Weizmann Institute of Science Avi Schroeder Technion Yuval Shaked Technion Ravid Straussman Weizmann Institute of Science Craig Thompson Memorial Sloan Kettering Cancer Center Andreas Trumpp Deutsches Krebs Forschungs Zentrum David Tuveson Cold Spring Harbor Laboratory Jennifer Wargo MD Anderson Cancer Center Valerie Weaver University of California San Francisco Jedd Wolchok Memorial Sloan Kettering Cancer Center CONFIRMED SPEAKERS Hosted by the Moross Integrated Cancer Center (Weizmann Institute of Science) and the Technion Integrated Cancer Center, the conference will address state-of-the-art issues in basic and translational cancer research, as well as their clinical implications. The conference will focus on recent cancer related discoveries pertaining to immunotherapy, genetic alterations, metabolism, the microbiome, tumor microenvironment, senescence, cancer progression and metastases, as well as innovative technologies in cancer therapy. 2-4 March, 2020 The David Lopatie Conference Centre Weizmann Institute of Science, Israel CONFERENCE COORDINATOR & ACCESSIBILITY ISSUES Talia Suissa [email protected] ORGANIZING COMMITTEE Varda Rotter, chair Ari Elson, co-chair Yuval Shaked Eyal Gottlieb Valery Krizhanovsky Avi Schroeder Ruth Scherz-Shouval ADMINISTRATIVE ORGANIZER Dina Preise [email protected] Save e Date From Basic Cancer Research to Innovative Therapies A number of student travel fellowships will be provided WEBSITE www.weizmann.ac.il/ conferences/MICC2020

Upload: others

Post on 25-Jan-2021

7 views

Category:

Documents


0 download

TRANSCRIPT

  • Ittai Ben PorathHebrew University of Jerusalem Yosef BuganimHebrew University of Jerusalem Arkaitz Carracedo CIC bioGUNEWebster Cavenee Ludwig Institute for Cancer Research, UCSD Rony DahanWeizmann Institute of Science John Dick UHN and University of Toronto Ayelet Erez Weizmann Institute of Science Neta ErezTel-Aviv University Naama Geva-ZatorskyTechnionEyal Gottlieb TechnionYona KeisariTel-Aviv University

    Mary-Claire KingUniversity of Washington Alan Korman Bristol-Meyers-Squibb Valery KrizhanovskyWeizmann Institute of Science Scott LoweMemorial Sloan Kettering Cancer Center David MalkinHospital for Sick Children & University of Toronto George MillerNew York University Moshe OrenWeizmann Institute of Science Gideon RechaviSheba Medical Center Varda RotterWeizmann Institute of Science Yardena SamuelsWeizmann Institute of ScienceAvigdor Scherz Weizmann Institute of Science

    Ruth Scherz-ShouvalWeizmann Institute of Science Avi SchroederTechnionYuval ShakedTechnionRavid Straussman Weizmann Institute of Science Craig ThompsonMemorial Sloan Kettering Cancer Center Andreas Trumpp Deutsches Krebs Forschungs Zentrum David TuvesonCold Spring Harbor Laboratory Jennifer WargoMD Anderson Cancer Center Valerie WeaverUniversity of California San Francisco Jedd WolchokMemorial Sloan Kettering Cancer Center

    CONFIRMED SPEAKERS

    Hosted by the Moross Integrated Cancer Center (Weizmann Institute of Science) and the Technion Integrated Cancer Center, the conference will address state-of-the-art issues in basic and translational cancer research, as well as their clinical implications. The conference will focus on recent cancer related discoveries pertaining to immunotherapy, genetic alterations, metabolism, the microbiome, tumor microenvironment, senescence, cancer progression and metastases, as well as innovative technologies in cancer therapy.

    2-4 March, 2020 The David Lopatie Conference Centre Weizmann Institute of Science, Israel

    CONFERENCE COORDINATOR & ACCESSIBILITY ISSUES Talia Suissa ENVELOPE [email protected]

    ORGANIZING COMMITTEE Varda Rotter, chair Ari Elson, co-chair Yuval ShakedEyal GottliebValery Krizhanovsky Avi SchroederRuth Scherz-Shouval

    ADMINISTRATIVE ORGANIZER Dina Preise ENVELOPE [email protected]

    Save the

    DateFrom Basic Cancer Research to Innovative Therapies

    A number of student travel fellowships will be provided

    WEBSITE

    www.weizmann.ac.il/conferences/MICC2020

    mailto:talias%40weizmann.ac.il%20?subject=mailto:dina.preise%40weizmann.ac.il?subject=mailto:talias%40weizmann.ac.il%20?subject=http://www.weizmann.ac.il/conferences/MICC2020/http://www.weizmann.ac.il/conferences/MICC2020/